Alumobility to Showcase Aluminum's Role in Sustainable Automotive Vehicles at the 27th Global Car Body Benchmarking Conference ZURICH, Oct. 13, 2025 /PRNewswire/ -- Alumobility, the global...

Presenting to investors in Track 3 on Monday, October 20th at 9:30am PT AZOUR, Israel, Oct. 13, 2025 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN), a global leader in vehicle...

New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC portfolio designed to target...

The leading expert in alternative equity solutions for the skilled trades will share insights and best practices to support employee retention LAS VEGAS, Oct. 13, 2025 /PRNewswire/ -- Reins, a...

Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian cancer HOLON, Israel, Oct....

Protecting the U.S. Military's NGSW Program with Mission-Ready Protective Transit Solutions TORRANCE, Calif., Oct. 13, 2025 /PRNewswire/ -- Pelican Products, Inc, the global leader in...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in November 2025. The Company will participate in...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral...

Join Daltile at one of their stores nationwide this week for big tile savings, exclusive vendor discounts, and the chance to win an all-expenses-paid trip to attend Oktoberfest 2026 in Europe. DALLAS,

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) will present data from its Phase 1a clinical trial evaluating LNP3693, a STING agonist,...